Synopsis
0
USDMF
0
CEP/COS
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
84
PharmaCompass offers a list of Diflucortolone Valerate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Diflucortolone Valerate manufacturer or Diflucortolone Valerate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diflucortolone Valerate manufacturer or Diflucortolone Valerate supplier.
A Nerisone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nerisone, including repackagers and relabelers. The FDA regulates Nerisone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nerisone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nerisone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Nerisone supplier is an individual or a company that provides Nerisone active pharmaceutical ingredient (API) or Nerisone finished formulations upon request. The Nerisone suppliers may include Nerisone API manufacturers, exporters, distributors and traders.
click here to find a list of Nerisone suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Nerisone Drug Master File in Japan (Nerisone JDMF) empowers Nerisone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Nerisone JDMF during the approval evaluation for pharmaceutical products. At the time of Nerisone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Nerisone suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nerisone Drug Master File in Korea (Nerisone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nerisone. The MFDS reviews the Nerisone KDMF as part of the drug registration process and uses the information provided in the Nerisone KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nerisone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nerisone API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nerisone suppliers with KDMF on PharmaCompass.
A Nerisone written confirmation (Nerisone WC) is an official document issued by a regulatory agency to a Nerisone manufacturer, verifying that the manufacturing facility of a Nerisone active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Nerisone APIs or Nerisone finished pharmaceutical products to another nation, regulatory agencies frequently require a Nerisone WC (written confirmation) as part of the regulatory process.
click here to find a list of Nerisone suppliers with Written Confirmation (WC) on PharmaCompass.
Nerisone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nerisone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Nerisone GMP manufacturer or Nerisone GMP API supplier for your needs.
A Nerisone CoA (Certificate of Analysis) is a formal document that attests to Nerisone's compliance with Nerisone specifications and serves as a tool for batch-level quality control.
Nerisone CoA mostly includes findings from lab analyses of a specific batch. For each Nerisone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nerisone may be tested according to a variety of international standards, such as European Pharmacopoeia (Nerisone EP), Nerisone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nerisone USP).
